Dopamine Agonists for Pituitary Adenomas

por Cooper, Odelia, Greenman, Yona
Publicado 2018

ODP643 Metabolic Effects of Growth Hormone Replacement in Craniopharyngioma and Pituitary Adenoma Patients: Analysis of the Hypopituitary Control and Complications Study (HypoCCS)...

por Cooper, Odelia, Kim, Sungjin
Publicado 2022

Editorial: Targeted Therapy for Pituitary Adenomas

por Araki, Takako, Cooper, Odelia, Fukuoka, Hidenori
Publicado 2019

Pembrolizumab-Induced Diabetic Ketoacidosis: A Review of Critical Care Case

por Sankar, Keerthana, Macfarlane, Matthew, Cooper, Odelia, Falk, Jeremy
Publicado 2021

Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder

por Cooper, Odelia, Bonert, Vivien, Moser, Franklin, Mirocha, James, Melmed, Shlomo
Publicado 2017

SUN-461 Predictors of Early and Late Hyponatremia after Pituitary Surgery

por Cooper, Odelia, Hwe, Jennifer, Puchalski, Adam, Bonert, Vivien, Mamelak, Adam
Publicado 2019

SUN-442 EGFR/ErbB2 Targeted Therapy for Aggressive Prolactinomas

por Cooper, Odelia, Bonert, Vivien, Rudnick, Jeremy, Pressman, Barry, Melmed, Shlomo
Publicado 2019

Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review

por Cooper, Odelia, Bonert, Vivien, Liu, Ning-Ai, Mamelak, Adam N.
Publicado 2021

PMON47 Fluid restriction reduces hyponatremia and hospital readmission rates following pituitary surgery

por Mamelak, Adam, Bonert, Vivien, Liu, Ning-Ai, BenShlomo, Anat, Labadzhyan, Artak, Malik, Risha, Shamouelian, Albert, Cooper, Odelia
Publicado 2022